Vimarsana
Biggest News Aggregation in the World

Page 8 - Algert Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Algert Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Algert Global Today - Breaking & Trending Today

Clearwater Paper (NYSE:CLW) Reaches New 52-Week High at $52.09 - Vimarsana News

Clearwater Paper (NYSE:CLW) Reaches New 52-Week High at $52.09

Clearwater Paper Co. (NYSE:CLW – Get Free Report)’s share price hit a new 52-week high on Monday . The stock traded as high as $52.09 and last traded at $52.09, with a volume of 20029 shares traded. The stock had previously closed at $51.47. Analyst Upgrades and Downgrades CLW has been the topic of several […]

Source: wkrb13.com
Brokers Offer Predictions for Cara Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CARA) - Vimarsana News

Brokers Offer Predictions for Cara Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CARA)

Cara Therapeutics, Inc. (NASDAQ:CARA – Free Report) – Equities researchers at HC Wainwright lifted their Q2 2024 earnings per share estimates for shares of Cara Therapeutics in a note issued to investors on Wednesday, May 15th. HC Wainwright analyst O. Livnat now expects that the biopharmaceutical company will post earnings per share of ($0.22) for […]

Source: wkrb13.com
Cara Therapeutics (NASDAQ:CARA) Stock Rating Reaffirmed by HC Wainwright - Vimarsana News

Cara Therapeutics (NASDAQ:CARA) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a report released on Wednesday, Benzinga reports. HC Wainwright currently has a $3.60 price target on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Cara Therapeutics’ Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings at ($0.15) […]

Source: wkrb13.com
Cara Therapeutics (NASDAQ:CARA) Given Buy Rating at HC Wainwright - Vimarsana News

Cara Therapeutics (NASDAQ:CARA) Given Buy Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Cara Therapeutics (NASDAQ:CARA – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $3.60 target price on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Cara Therapeutics’ Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings […]

Marathon Capital Management Reduces Holdings in TETRA Technologies, Inc. (NYSE:TTI) - Vimarsana News

Marathon Capital Management Reduces Holdings in TETRA Technologies, Inc. (NYSE:TTI)

Marathon Capital Management cut its position in TETRA Technologies, Inc. (NYSE:TTI – Free Report) by 10.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,295,445 shares of the oil and gas company’s stock after selling 146,675 shares during the quarter. […]